Isothermal Nucleic Acid Amplification Technology Market Size, Top Share, Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Isothermal Nucleic Acid Amplification Technology Market Size Analysis

Global Isothermal Nucleic Acid Amplification Technology Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Reagent
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Transcription Mediated Amplification (TMA)
    1. By Value
  3. Loop-mediated isothermal amplification (LAMP)
    1. By Value
  4. Strand Displacement Amplification (SDA)
    1. By Value
  5. Helicase-dependent Amplification (HDA)
    1. By Value
  6. Nucleic Acid Sequence-based Amplification (NASBA)
    1. By Value
  7. Nicking Enzyme Amplification Reaction (NEAR)
    1. By Value
  8. Single Primer Isothermal Amplification (SPIA)
    1. By Value
  9. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Blood screening
    1. By Value
  3. Infectious disease diagnostics
    1. By Value
  4. Cancer
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals
    1. By Value
  3. Central and reference labs
    1. By Value
  4. Other
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Reagent
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Transcription Mediated Amplification (TMA)
    1. By Value
  3. Loop-mediated isothermal amplification (LAMP)
    1. By Value
  4. Strand Displacement Amplification (SDA)
    1. By Value
  5. Helicase-dependent Amplification (HDA)
    1. By Value
  6. Nucleic Acid Sequence-based Amplification (NASBA)
    1. By Value
  7. Nicking Enzyme Amplification Reaction (NEAR)
    1. By Value
  8. Single Primer Isothermal Amplification (SPIA)
    1. By Value
  9. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Blood screening
    1. By Value
  3. Infectious disease diagnostics
    1. By Value
  4. Cancer
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals
    1. By Value
  3. Central and reference labs
    1. By Value
  4. Other
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Reagent
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Transcription Mediated Amplification (TMA)
    1. By Value
  3. Loop-mediated isothermal amplification (LAMP)
    1. By Value
  4. Strand Displacement Amplification (SDA)
    1. By Value
  5. Helicase-dependent Amplification (HDA)
    1. By Value
  6. Nucleic Acid Sequence-based Amplification (NASBA)
    1. By Value
  7. Nicking Enzyme Amplification Reaction (NEAR)
    1. By Value
  8. Single Primer Isothermal Amplification (SPIA)
    1. By Value
  9. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Blood screening
    1. By Value
  3. Infectious disease diagnostics
    1. By Value
  4. Cancer
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals
    1. By Value
  3. Central and reference labs
    1. By Value
  4. Other
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Reagent
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Transcription Mediated Amplification (TMA)
    1. By Value
  3. Loop-mediated isothermal amplification (LAMP)
    1. By Value
  4. Strand Displacement Amplification (SDA)
    1. By Value
  5. Helicase-dependent Amplification (HDA)
    1. By Value
  6. Nucleic Acid Sequence-based Amplification (NASBA)
    1. By Value
  7. Nicking Enzyme Amplification Reaction (NEAR)
    1. By Value
  8. Single Primer Isothermal Amplification (SPIA)
    1. By Value
  9. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Blood screening
    1. By Value
  3. Infectious disease diagnostics
    1. By Value
  4. Cancer
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals
    1. By Value
  3. Central and reference labs
    1. By Value
  4. Other
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Instruments
  1. By Value
3. Reagent
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Transcription Mediated Amplification (TMA)
  1. By Value
3. Loop-mediated isothermal amplification (LAMP)
  1. By Value
4. Strand Displacement Amplification (SDA)
  1. By Value
5. Helicase-dependent Amplification (HDA)
  1. By Value
6. Nucleic Acid Sequence-based Amplification (NASBA)
  1. By Value
7. Nicking Enzyme Amplification Reaction (NEAR)
  1. By Value
8. Single Primer Isothermal Amplification (SPIA)
  1. By Value
9. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Blood screening
  1. By Value
3. Infectious disease diagnostics
  1. By Value
4. Cancer
  1. By Value
5. Others
  1. By Value
By End-use
1. Introduction
  1. End-use By Value
2. Hospitals
  1. By Value
3. Central and reference labs
  1. By Value
4. Other
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Instruments
    1. By Value
  3. Reagent
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Transcription Mediated Amplification (TMA)
    1. By Value
  3. Loop-mediated isothermal amplification (LAMP)
    1. By Value
  4. Strand Displacement Amplification (SDA)
    1. By Value
  5. Helicase-dependent Amplification (HDA)
    1. By Value
  6. Nucleic Acid Sequence-based Amplification (NASBA)
    1. By Value
  7. Nicking Enzyme Amplification Reaction (NEAR)
    1. By Value
  8. Single Primer Isothermal Amplification (SPIA)
    1. By Value
  9. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Blood screening
    1. By Value
  3. Infectious disease diagnostics
    1. By Value
  4. Cancer
    1. By Value
  5. Others
    1. By Value
4. By End-use
  1. Introduction
    1. End-use By Value
  2. Hospitals
    1. By Value
  3. Central and reference labs
    1. By Value
  4. Other
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Isothermal Nucleic Acid Amplification Technology Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Ustar Biotechnologies (Hangzhou) Ltd.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Hologic, Inc.
Abbott
Thermo Fisher Scientific Inc.
QIAGEN
Meridian Bioscience
Eiken Chemical Co., Ltd.
GENEYE
CANON MEDICAL SYSTEMS CORPORATION
Sysmex Europe SE
Enzo Biochem Inc.
New England Biolabs
TwistDx Limited
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment